131I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

被引：0
|
作者：
Gonca Kara Gedik
Cornelis A. Hoefnagel
Evert Bais
Renato A. Valdés Olmos
机构：
[1] Hacettepe University School of Medicine,Department of Nuclear Medicine, Faculty of Medicine
[2] The Netherlands Cancer Institute,Department of Nuclear Medicine
[3] The Netherlands Cancer Institute,Department of Medical Oncology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2008年 / 35卷
关键词：
I-MIBG; Phaeochromocytoma; Paraganglioma; Malignant; Radionuclide therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：725 / 733
页数：8
相关论文
共 50 条
  • [31] EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
    Giammarile, Francesco
    Chiti, Arturo
    Lassmann, Michael
    Brans, Boudewijn
    Flux, Glenn
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (05) : 1039 - 1047
  • [32] EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
    Francesco Giammarile
    Arturo Chiti
    Michael Lassmann
    Boudewijn Brans
    Glenn Flux
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1039 - 1047
  • [33] Individualised 131I-mIBG Therapy in the Management of Refractory and Relapsed Neuroblastoma
    George, S. L.
    Kirk, S. J.
    Lancaster, D.
    Vaidya, S. J.
    Mandeville, H.
    Saran, F.
    Chittenden, S. J.
    Pearson, A. D. J.
    Du, Y.
    Flux, G. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S244 - S244
  • [34] 131I-MIBG therapy: Dosimetry estimations in neuroendocrine patients.
    Castellani, M. R.
    Chiesa, C.
    Luksch, R.
    Aliberti, A.
    Maccauro, M.
    Seregni, E.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S317 - S317
  • [35] 131I－MIBG标记条件研究
    陈大明，金小海，杜进，刘跃民，王凡
    同位素, 1995, (01) : 12 - 15
  • [36] Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
    Wakabayashi, Hiroshi
    Taki, Junichi
    Inaki, Anri
    Nakamura, Ayane
    Kayano, Daiki
    Fukuoka, Makoto
    Matsuo, Shinro
    Nakajima, Kenichi
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (09) : 839 - 846
  • [37] Personalized Thera(g)nostic Approach in Patients with Pheochromocytoma and Paraganglioma: 131I-mIBG and/or Peptide Receptor Radionuclide Therapy
    Svirydenka, H.
    Nilica, B.
    Mair, C.
    Rossetti, L.
    Kroiss, A.
    Di Santo, G.
    Buxbaum, S.
    Decristoforo, C.
    Uprimny, C.
    Gabriel, M.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S278 - S278
  • [38] Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
    Hiroshi Wakabayashi
    Junichi Taki
    Anri Inaki
    Ayane Nakamura
    Daiki Kayano
    Makoto Fukuoka
    Shinro Matsuo
    Kenichi Nakajima
    Seigo Kinuya
    Annals of Nuclear Medicine, 2013, 27 : 839 - 846
  • [39] The impact of 131I-mIBG rescue therapy in the survival of a patient with ganglioneuroblastoma
    Parra, A. T. T.
    Moriguchi, S. M.
    Goncalves, M. C. P.
    Esteves, M. A. M. F. F.
    Santos, M. J.
    Gracioli, L. M.
    Boldrini, E.
    Rocha, E. T.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 : S42 - S42
  • [40] Intraarterial 131I-MIBG therapy of neuroendocrine tumours with liver metastases
    Popp, M.
    Strumpf, A.
    Zoephel, K.
    Stroszczynski, C.
    Kotzerke, J.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2010, 49 (01): : N2 - N3
12345